A detailed history of Peterson Financial Group, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Peterson Financial Group, Inc. holds 276 shares of ABT stock, worth $32,830. This represents 0.12% of its overall portfolio holdings.

Number of Shares
276
Holding current value
$32,830
% of portfolio
0.12%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$100.07 - $118.13 $27,619 - $32,603
276 New
276 $31.5 Million
Q3 2023

Oct 31, 2023

BUY
$95.53 - $114.62 $74,035 - $88,830
775 Added 7.59%
10,989 $1.06 Million
Q2 2023

Aug 04, 2023

BUY
$100.78 - $112.29 $1.03 Million - $1.15 Million
10,214 New
10,214 $1.11 Million
Q4 2022

Aug 27, 2024

BUY
$95.06 - $111.52 $1.38 Million - $1.62 Million
14,548 New
14,548 $1.6 Billion
Q3 2022

Aug 26, 2024

BUY
$96.76 - $112.03 $86,503 - $100,154
894 Added 4.2%
22,171 $2.15 Billion
Q3 2022

Oct 17, 2022

BUY
$96.76 - $112.03 $55,927 - $64,753
578 Added 2.62%
22,671 $2.19 Million
Q2 2022

Aug 26, 2024

BUY
$102.07 - $123.37 $2.17 Million - $2.62 Million
21,277 New
21,277 $2.31 Billion
Q2 2022

Jul 20, 2022

BUY
$102.07 - $123.37 $178,928 - $216,267
1,753 Added 8.62%
22,093 $2.4 Million
Q1 2022

Aug 26, 2024

BUY
$114.02 - $139.04 $2.25 Million - $2.74 Million
19,712 New
19,712 $2.33 Billion
Q1 2022

Jul 19, 2022

SELL
$114.02 - $139.04 $6,955 - $8,481
-61 Reduced 0.3%
20,340 $2.41 Million
Q1 2022

Apr 18, 2022

SELL
$114.02 - $139.04 $4.23 Million - $5.16 Million
-37,133 Reduced 64.54%
20,401 $2.42 Million
Q4 2021

Aug 22, 2024

BUY
$115.53 - $141.46 $2.13 Million - $2.61 Million
18,479 New
18,479 $2.6 Billion
Q4 2021

Jan 31, 2022

BUY
$115.53 - $141.46 $6.65 Million - $8.14 Million
57,534 New
57,534 $8.1 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $208B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Peterson Financial Group, Inc. Portfolio

Follow Peterson Financial Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peterson Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Peterson Financial Group, Inc. with notifications on news.